Skip to main content

Table 5 Drug treatment of adherents and nonadherent hypertensive people drug treatment, during the COVID-19 pandemic

From: Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study

Variable

Adherence

P-value

Yes

No

Total

No. of prescribed drugs

7.1 ± 2.6

6.8 ± 2.6

7.4 ± 2.8

0.412a

No. of antihypertensives prescribed

3.2 ± 1.1

3.3 ± 1.2

3.2 ± 1.2

0.563b

 1

10 (6.1)

8 (6.9)

18 (6.0)

0.645a

 2–3

89 (53.9)

56 (48.3)

145 (52.0)

 

 ≥ 4

66 (40.0)

52 (44.8)

118 (42.0)

 

Acquisition of antihypertensive drugs

 Buy

11 (6.7)

8 (6.9)

19 (6.8)

0.203c

 Pick it up directly at the hospital pharmacy or popular pharmacy

27 (16.4)

25 (21.6)

52 (18.5)

 

 Receive from the hospital at home by mail

88 (53.3)

67 (57.7)

155 (55.2)

 

 Pick up at the health center

39 (23.6)

16 (13.8)

55 (19.5)

 

Difficulties during the pandemic to acquire antihypertensive drugs

 Hospital related

  Failed to deliver or was delayed

33 (37.5)

31 (46.3)

64 (22.6)

0.396c

  Partially received the medicines

23 (26.1)

12 (17.9)

35 (41.3)

 

  There was no difficulty

32 (36.4)

24 (35.8)

56 (36.1)

 

 Health center related

  Yes

11 (28.2)

6 (37.5)

17 (30.9)

0.533c

  No

28 (71.8)

10 (62.5)

38 (69.1)

 

Ran out of antihypertensive medication during quarantine

 Yes

10 (6.1)

18 (15.5)

28 (10.0)

0.009b

 No

155 (93.9)

98 (84.5)

253 (90.0)

 
  1. Data are presented as mean ± standard deviation or number (%)
  2. P-value obtained by at-test,
  3. blikelihood ratio, and
  4. cPearson chi-test